Holdings
First Turn Management, LLC
As of Sep 30, 2026, First Turn Management, LLC reported 35 positions worth US$712M. Largest: Enliven Therapeutics, Inc., Guardant Health, Inc. and Abivax SA. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Enliven Therapeutics, Inc. | 959K | US$43.9M | +4,340 | Sep 30, 2026 |
| Guardant Health, Inc. | 219K | US$39.1M | new | Sep 30, 2026 |
| Abivax SA | 385K | US$38.1M | −105K | Sep 30, 2026 |
| Roivant Sciences Ltd. | 986K | US$36M | −345K | Sep 30, 2026 |
| United Therapeutics Corporation | 60,064 | US$32.5M | −24,868 | Sep 30, 2026 |
| Viridian Therapeutics, Inc. | 1.53M | US$31.4M | −145K | Sep 30, 2026 |
| Axsome Therapeutics, Inc. | 162K | US$29.9M | −56,008 | Sep 30, 2026 |
| Insmed Incorporated | 246K | US$28M | −18,125 | Sep 30, 2026 |
| Celcuity Inc. | 329K | US$26.2M | no change | Sep 30, 2026 |
| Charles River Laboratories International, Inc. | 86,801 | US$25.6M | new | Sep 30, 2026 |